Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin).
Larson RA, Boogaerts M, Estey E, Karanes C, Stadtmauer EA, Sievers EL, Mineur P, Bennett JM, Berger MS, Eten CB, Munteanu M, Loken MR, Van Dongen JJ, Bernstein ID, Appelbaum FR. Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin). Leukemia. 2002 Sep; 16(9):1627-36.
-
Acute Disease
-
Adult
-
Aged
-
Aged, 80 and over
-
Aminoglycosides
-
Anti-Bacterial Agents
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antigens, CD
-
Antigens, Differentiation, Myelomonocytic
-
Disease-Free Survival
-
Female
-
Humans
-
Immunotoxins
-
Leukemia, Myeloid
-
Male
-
Middle Aged
-
Monitoring, Physiologic
-
Neoplasm Recurrence, Local
-
Prognosis
-
Survival Rate